{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T08:05:24Z","timestamp":1779869124172,"version":"3.53.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Arab Journal of Gastroenterology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.ajg.2026.03.002","type":"journal-article","created":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T11:35:17Z","timestamp":1776944117000},"page":"213-223","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The mutational and transcriptional status of RYR in CRC and its indication for prognosis"],"prefix":"10.1016","volume":"27","author":[{"given":"Jiangping","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minxuan","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qi","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.ajg.2026.03.002_b0005","doi-asserted-by":"crossref","first-page":"8","DOI":"10.2174\/1874467208666150507093116","article-title":"Calcium Channel Signaling Complexes with Receptors and Channels","volume":"8","author":"Zamponi","year":"2015","journal-title":"Curr Mol Pharmacol."},{"issue":"1","key":"10.1016\/j.ajg.2026.03.002_b0010","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1517\/14728214.11.1.49","article-title":"Calcium-channel modulators for cardiovascular disease","volume":"11","author":"Godfraind","year":"2006","journal-title":"Expert Opin Emerg Drugs."},{"issue":"6","key":"10.1016\/j.ajg.2026.03.002_b0015","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1002\/jnr.10872","article-title":"Calcium channel blockers in the treatment of disease","volume":"75","author":"Elmslie","year":"2004","journal-title":"J Neurosci Res."},{"key":"10.1016\/j.ajg.2026.03.002_b0020","doi-asserted-by":"crossref","unstructured":"Santulli G, Lewis D, des Georges A, Marks AR, Frank J. Ryanodine Receptor Structure and Function in Health and Disease. Subcell Biochem. 2018;87:329-352. doi: 10.1007\/978-981-10-7757-9_11. PMID: 29464565; PMCID: PMC5936639.","DOI":"10.1007\/978-981-10-7757-9_11"},{"key":"10.1016\/j.ajg.2026.03.002_b0025","unstructured":"Raszewski JA, Sharma S. Physiology, Ryanodine Receptor. 2021 Sep 28. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2021 Jan\u2013. PMID: 30855907."},{"issue":"9","key":"10.1016\/j.ajg.2026.03.002_b0030","article-title":"Cardiac ryanodine receptor distribution is dynamic and changed by auxiliary proteins and post-translational modification","volume":"9","author":"Asghari","year":"2020","journal-title":"Elife."},{"issue":"2","key":"10.1016\/j.ajg.2026.03.002_b0035","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.tips.2005.12.008","article-title":"The role of the endoplasmic reticulum Ca2+ store in the plasticity of central neurons","volume":"27","author":"Bardo","year":"2006","journal-title":"Trends Pharmacol Sci."},{"issue":"6868","key":"10.1016\/j.ajg.2026.03.002_b0040","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/415198a","article-title":"Cardiac excitation-contraction coupling","volume":"415","author":"Bers","year":"2002","journal-title":"Nature."},{"issue":"6","key":"10.1016\/j.ajg.2026.03.002_b0045","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.tibs.2020.11.009","article-title":"Structural Basis for the Modulation of Ryanodine Receptors","volume":"46","author":"Gong","year":"2021","journal-title":"Trends Biochem Sci."},{"key":"10.1016\/j.ajg.2026.03.002_b0050","doi-asserted-by":"crossref","unstructured":"Kefauver JM, Ward AB, Patapoutian A. Discoveries in structure and physiology of mechanically activated ion channels. Nature. 2020 Nov;587(7835):567-576. doi: 1038\/s41586-020-2933-1. Epub 2020 Nov 25. PMID: 33239794; PMCID: PMC8477435.","DOI":"10.1038\/s41586-020-2933-1"},{"issue":"10","key":"10.1016\/j.ajg.2026.03.002_b0055","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.2174\/0929867311320100005","article-title":"Ion channels as drug targets in central nervous system disorders","volume":"20","author":"Waszkielewicz","year":"2013","journal-title":"Curr Med Chem."},{"issue":"3","key":"10.1016\/j.ajg.2026.03.002_b0060","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1152\/physrev.00024.2019","article-title":"Cardiac transmembrane ion channels and action potentials: cellular physiology and arrhythmogenic behavior","volume":"101","author":"Varr\u00f3","year":"2021","journal-title":"Physiol Rev."},{"issue":"2","key":"10.1016\/j.ajg.2026.03.002_b0065","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1152\/physrev.00044.2016","article-title":"Ion Channels in Cancer: Are Cancer Hallmarks Oncochannelopathies?","volume":"98","author":"Prevarskaya","year":"2018","journal-title":"Physiol Rev."},{"issue":"38","key":"10.1016\/j.ajg.2026.03.002_b0070","doi-asserted-by":"crossref","first-page":"5732","DOI":"10.3748\/wjg.v25.i38.5732","article-title":"Role of ion channels in gastrointestinal cancer","volume":"25","author":"Anderson","year":"2019","journal-title":"World J Gastroenterol."},{"issue":"6","key":"10.1016\/j.ajg.2026.03.002_b0075","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bbamcr.2017.01.005","article-title":"Calcium remodeling in colorectal cancer","volume":"1864","author":"Villalobos","year":"2017","journal-title":"Biochim Biophys Acta Mol Cell Res."},{"issue":"126","key":"10.1016\/j.ajg.2026.03.002_b0080","first-page":"155","article-title":"Epigenetic regulation of voltage-gated potassium ion channel molecule Kv1.3 in mechanisms of colorectal cancer","volume":"23","author":"He","year":"2017","journal-title":"Discov Med."},{"key":"10.1016\/j.ajg.2026.03.002_b0085","doi-asserted-by":"crossref","unstructured":"Zhang M, Li T, Zhu J, Tuo B, Liu X. Physiological and pathophysiological role of ion channels and transporters in the colorectum and colorectal cancer. J Cell Mol Med. 2020 Sep;24(17):9486-9494. doi: 10.1111\/jcmm.15600. Epub 2020 Jul 13. PMID: 32662230; PMCID: PMC7520301.","DOI":"10.1111\/jcmm.15600"},{"issue":"11","key":"10.1016\/j.ajg.2026.03.002_b0090","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1158\/1541-7786.MCR-19-0429","article-title":"A Complex Role for Calcium Signaling in Colorectal Cancer Development and Progression","volume":"17","author":"Wang","year":"2019","journal-title":"Mol Cancer Res."},{"issue":"1","key":"10.1016\/j.ajg.2026.03.002_b0095","doi-asserted-by":"crossref","first-page":"16113","DOI":"10.1038\/s41598-022-19905-y","article-title":"The ryanodine receptor mutational characteristics and its indication for cancer prognosis","volume":"12","author":"Wang","year":"2022","journal-title":"Sci Rep."},{"issue":"12","key":"10.1016\/j.ajg.2026.03.002_b0100","doi-asserted-by":"crossref","first-page":"3299","DOI":"10.1002\/ijc.32481","article-title":"Somatic mutations and promotor methylation of the ryanodine receptor 2 is a common event in the pathogenesis of head and neck cancer","volume":"145","author":"Schmitt","year":"2019","journal-title":"Int J Cancer."},{"key":"10.1016\/j.ajg.2026.03.002_b0105","doi-asserted-by":"crossref","unstructured":"Cui C, Merritt R, Fu L, Pan Z. Targeting calcium signaling in cancer therapy. Acta Pharm Sin B. 2017 Jan;7(1):3-17. doi: 10.1016\/j.apsb.2016.11.001. Epub 2016 Dec 13. PMID: 28119804; PMCID: PMC5237760.","DOI":"10.1016\/j.apsb.2016.11.001"},{"issue":"1","key":"10.1016\/j.ajg.2026.03.002_b0110","doi-asserted-by":"crossref","first-page":"3644","DOI":"10.1038\/s41467-020-17386-z","article-title":"Landscape of somatic single nucleotide variants and indels in colorectal cancer and impact on survival","volume":"11","author":"Zaidi","year":"2020","journal-title":"Nat Commun."},{"issue":"1","key":"10.1016\/j.ajg.2026.03.002_b0115","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","article-title":"Clinical Sequencing Defines the Genomic Landscape of Metastatic Colorectal Cancer","volume":"33","author":"Yaeger","year":"2018","journal-title":"Cancer Cell."},{"key":"10.1016\/j.ajg.2026.03.002_b0120","doi-asserted-by":"crossref","unstructured":"Chen T, Zhang X, Ding X, Feng J, Zhang X, Xie D, Wang X. Ryanodine receptor 2 promotes colorectal cancer metastasis by the ROS\/BACH1 axis. Mol Oncol. 2023 Apr;17(4):695-709. doi: 10.1002\/1878-0261.13350. Epub 2022 Dec 21. PMID: 36453019; PMCID: PMC10061290.","DOI":"10.1002\/1878-0261.13350"},{"issue":"8","key":"10.1016\/j.ajg.2026.03.002_b0125","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1093\/annonc\/mdz116","article-title":"ESMO recommendations on microsatellite instability testing for immunotherapy in cancer, and its relationship with PD-1\/PD-L1 expression and tumour mutational burden: a systematic review-based approach","volume":"30","author":"Luchini","year":"2019","journal-title":"Ann Oncol."},{"key":"10.1016\/j.ajg.2026.03.002_b0130","doi-asserted-by":"crossref","unstructured":"Samstein RM, Lee CH, Shoushtari AN, Hellmann MD, Shen R, Janjigian YY, Barron DA, Zehir A, Jordan EJ, Omuro A, Kaley TJ, Kendall SM, Motzer RJ, Hakimi AA, Voss MH, Russo P, Rosenberg J, Iyer G, Bochner BH, Bajorin DF, Al-Ahmadie HA, Chaft JE, Rudin CM, Riely GJ, Baxi S, Ho AL, Wong RJ, Pfister DG, Wolchok JD, Barker CA, Gutin PH, Brennan CW, Tabar V, Mellinghoff IK, DeAngelis LM, Ariyan CE, Lee N, Tap WD, Gounder MM, D'Angelo SP, Saltz L, Stadler ZK, Scher HI, Baselga J, Razavi P, Klebanoff CA, Yaeger R, Segal NH, Ku GY, DeMatteo RP, Ladanyi M, Rizvi NA, Berger MF, Riaz N, Solit DB, Chan TA, Morris LGT. Tumor mutational load predicts survival after immunotherapy across multiple cancer types. Nat Genet. 2019 Feb;51(2):202-206. doi: 10.1038\/s41588-018-0312-8. Epub 2019 Jan 14. PMID: 30643254; PMCID: PMC6365097.","DOI":"10.1038\/s41588-018-0312-8"},{"issue":"10","key":"10.1016\/j.ajg.2026.03.002_b0135","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1016\/S1470-2045(20)30445-9","article-title":"Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 study","volume":"21","author":"Marabelle","year":"2020","journal-title":"Lancet Oncol."},{"issue":"12","key":"10.1016\/j.ajg.2026.03.002_b0140","article-title":"Association ofRYR2Mutation With Tumor Mutation Burden, Prognosis, and Antitumor Immunity in Patients With Esophageal Adenocarcinoma","volume":"17","author":"Liu","year":"2021","journal-title":"Front Genet."},{"key":"10.1016\/j.ajg.2026.03.002_b0145","doi-asserted-by":"crossref","unstructured":"Alborelli I, Leonards K, Rothschild SI, Leuenberger LP, Savic Prince S, Mertz KD, et al. Tumor mutational burden assessed by targeted NGS predicts clinical benefit from immune checkpoint inhibitors in non-small cell lung cancer. J Pathol. 2020 Jan;250(1):19- doi: 10.1002\/path.5344. Epub 2019 Oct 24. PMID: 31471895; PMCID: PMC6972587.","DOI":"10.1002\/path.5344"},{"issue":"4","key":"10.1016\/j.ajg.2026.03.002_b0150","article-title":"Mutational Profile Evaluates Response and Survival to First-Line Chemotherapy in Lung Cancer","volume":"8","author":"He","year":"2020","journal-title":"Adv Sci (Weinh)."},{"key":"10.1016\/j.ajg.2026.03.002_b0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106868","article-title":"Identification and validation of an immune prognostic signature in colorectal cancer","volume":"88","author":"Li","year":"2020","journal-title":"Int Immunopharmacol."},{"issue":"7","key":"10.1016\/j.ajg.2026.03.002_b0160","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.21037\/tcr-21-2395","article-title":"Ryanodine receptor (RYR) mutational status correlates with tumor mutational burden, age and smoking status and stratifies non-small cell lung cancer patient prognosis","volume":"11","author":"Wang","year":"2022","journal-title":"Transl Cancer Res."},{"issue":"7","key":"10.1016\/j.ajg.2026.03.002_b0165","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1093\/annonc\/mdz134","article-title":"Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer","volume":"30","author":"Schrock","year":"2019","journal-title":"Ann Oncol."}],"container-title":["Arab Journal of Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1687197926000390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T07:29:48Z","timestamp":1779866988000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1687197926000390"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S1687197926000390"],"URL":"https:\/\/doi.org\/10.1016\/j.ajg.2026.03.002","relation":{},"ISSN":["1687-1979"],"issn-type":[{"value":"1687-1979","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The mutational and transcriptional status of RYR in CRC and its indication for prognosis","name":"articletitle","label":"Article Title"},{"value":"Arab Journal of Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajg.2026.03.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Pan-Arab Association of Gastroenterology. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}